Effects of Methylphenidate and Bupropion on DHEA-S and Cortisol Plasma Levels in Attention-deficit Hyperactivity Disorder
- 31 August 2007
- journal article
- research article
- Published by Springer Nature in Child Psychiatry and Human Development
- Vol. 39 (2) , 201-209
- https://doi.org/10.1007/s10578-007-0081-6
Abstract
We evaluated plasma levels of DHEA-S and cortisol before and after treating ADHD patients with one of two medications: methylphenidate (n = 12) or bupropion (n = 10). Boys with ADHD (combined type) were evaluated with the Korean ADHD rating scale (K-ARS) and the computerized ADHD diagnostic system (ADS). All assessments were measured at baseline and repeated after 12 weeks. There were significant clinical improvements in both treatment groups as measured by K-ARS and ADS. DHEA-S levels increased from baseline to endpoint, but cortisol levels did not change significantly. This study suggests that both methylphenidate and bupropion increase plasma levels of DHEA-S in boys with ADHD.Keywords
This publication has 23 references indexed in Scilit:
- Dehydroepiandrosterone Sulfate and Allopregnanolone Directly Stimulate Catecholamine Production via Induction of Tyrosine Hydroxylase and Secretion by Affecting Actin PolymerizationEndocrinology, 2005
- The Neuropsychopharmacology of Attention-Deficit/Hyperactivity DisorderBiological Psychiatry, 2005
- Steroids, neuroactive steroids and neurosteroids in psychopathologyProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2005
- Methylphenidate: Its Pharmacology and UsesMayo Clinic Proceedings, 2000
- Methylphenidate: Its Pharmacology and UsesMayo Clinic Proceedings, 2000
- Treatment of Attention-Deficit–Hyperactivity DisorderNew England Journal of Medicine, 1999
- Role of Serotonin in the Paradoxical Calming Effect of Psychostimulants on HyperactivityScience, 1999
- Bupropion Hydrochloride in Attention Deficit Disorder with HyperactivityJournal of the American Academy of Child & Adolescent Psychiatry, 1996
- Bupropion versus Methylphenidate in the Treatment of Attention-Deficit Hyperactivity DisorderJournal of the American Academy of Child & Adolescent Psychiatry, 1995
- Receptor binding and electrophysiological effects of Dehydroepiandrosterone sulfate, an antagonist of the GABAA receptorNeuroscience, 1991